| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/04/2022 | GENOCEA BIOSCIENCES, INC. | GNCA | Sale | Common Stock | 1.1k | $1.25 | $1.4k | | 04/04/2022 |
| 03/16/2022 | GENOCEA BIOSCIENCES, INC. | GNCA | Sale | Common Stock | 2.7k | $1.10 | $3k | | 03/15/2022 |
| 03/15/2022 | GENOCEA BIOSCIENCES, INC. | GNCA | Grant | Stock Option (Right to Buy) | 93.8k | $1.11 | $104.1k | | 03/15/2022 |
| 03/15/2022 | GENOCEA BIOSCIENCES, INC. | GNCA | Grant | Common Stock | 31.2k | $0.00 | $0 | | 03/15/2022 |
| 03/15/2021 | GENOCEA BIOSCIENCES, INC. | GNCA | Grant | Restricted Stock Unit | 100k | $0.00 | $0 | | 03/15/2021 |
| 03/15/2021 | GENOCEA BIOSCIENCES, INC. | GNCA | Grant | Stock Option (Right to Buy) | 93.8k | $3.01 | $282.2k | | 03/15/2021 |
| 03/15/2021 | GENOCEA BIOSCIENCES, INC. | GNCA | Grant | Common Stock | 31.2k | $0.00 | $0 | | 03/15/2021 |
| 06/01/2020 | GENOCEA BIOSCIENCES, INC. | GNCA | Grant | Stock Option (Right to Buy) | 24.9k | $2.72 | $67.8k | | 06/01/2020 |
| 06/01/2020 | GENOCEA BIOSCIENCES, INC. | GNCA | Grant | Common Stock | 6.6k | $0.00 | $0 | | 06/01/2020 |
| 04/02/2020 | GENOCEA BIOSCIENCES, INC. | GNCA | Grant | Stock Option (Right to Buy) | 46.3k | $1.66 | $76.9k | | 04/02/2020 |
| 04/02/2020 | GENOCEA BIOSCIENCES, INC. | GNCA | Grant | Common Stock | 12.3k | $0.00 | $0 | | 04/02/2020 |
| 02/07/2019 | GENOCEA BIOSCIENCES, INC. | GNCA | Grant | Stock Option (Right to Buy) | 300k | $0.54 | $162k | | 02/07/2019 |
| 10/01/2018 | GENOCEA BIOSCIENCES, INC. | GNCA | Grant | Stock Option (Right to Buy) | 500k | $0.79 | $395k | | 10/01/2018 |
| 06/15/2017 | Celldex Therapeutics, Inc. | CLDX | Grant | | 150k | $2.32 | $348k | | 06/15/2017 |
| 07/01/2013 | Celldex Therapeutics, Inc. | CLDX | Grant | Incentive Stock Option | 115k | $16.36 | $1.9M | | 07/01/2013 |
| 09/12/2012 | Celldex Therapeutics, Inc. | CLDX | Grant | Incentive Stock Option | 115k | $5.69 | $654.4k | | 09/12/2012 |
| 08/05/2011 | Celldex Therapeutics, Inc. | CLDX | Grant | Incentive Stock Option | 104.5k | $2.80 | $292.6k | | 08/05/2011 |